Intriguingly, upregulation of PHLDB3 was significantly correlated with rare TP53 mutations in breast cancer, breast invasive carcinoma and esophageal carcinoma as revealed by the analysis of cBioPortal databases25, 26 (Fig. 3d,e). The gene discussed is TP53; the disease is carcinoma of esophagus.